Drug intelligence / Profile preview

alternaria alternata allergen extract

Development stage
Phase 4
Lead developer
Bial
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual, Intradermal, Topical
01

Overview

Alternaria alternata allergen extract is a biological product derived from the common mold *Alternaria alternata*. It is used for both the diagnosis and treatment of allergies to this fungus, which are a significant cause of respiratory conditions like allergic rhinitis and asthma. For diagnosis, the extract is used in skin prick tests and bronchial challenges to identify sensitivity in patients. As a therapeutic, it is the active component in allergen-specific immunotherapy (AIT), which aims to desensitize the patient's immune system. This immunotherapy works by administering controlled doses of the allergen, either via subcutaneous injection or sublingually, to modulate the immune response and build tolerance. To improve safety and reduce the high rate of adverse reactions associated with native extracts, modified versions called allergoids are developed. These are often created by treating the native extract with substances like glutaraldehyde, which polymerizes the proteins, reducing their ability to bind to IgE while retaining their immunogenicity. These polymerized extracts, such as Clustoid MAX Alternaria and Depigoid Alternaria alternata, allow for safer administration at higher concentrations.

Brand names
Clustoid MAX AlternariaDepigoid Alternaria alternata
Other names
Alternaria alternata allergoidglutaraldehyde-polymerized Alternaria alternata extractpolymerized A. alternata extractdepigmented allergoid
02

Targets

IgE (Immunoglobulin E)BCR (Immunoglobulin G B Cell Receptor)TCR (T cell antigen receptor complex)

Beyond the preview

Go deeper on alternaria alternata allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alternaria alternata allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call